Award
NIH Reporter #5R01AG096179-02
Examining Effects of Intensive BP Control on MCI/Dementia and Plasma Biomarker Trajectories by AD Pathology: Elucidating neuroprotective effects in the SPRINT trial
Recipient
Dr. Adam P Bress
Award Amount
$5,000,000.00
Ceiling
$5,000,000.00
Awarded
July 27, 2026
Identifier
5R01AG096179-02
NIH grant awarded to study the neuroprotective effects of intensive blood pressure control on mild cognitive impairment and dementia using biomarker data from the SPRINT trial.
Description
This NIH-funded project, under grant number 5R01AG096179-02, is led by Dr. Adam P Bress at the University of Utah, focusing on neuroprotective effects in older adults at risk for dementia, with a budget of approximately $5 million for the award period starting in 2026.